Covid-19 roundup: Biden plans for ear­ly No­vem­ber roll­out of vac­cines for kids; EMA eval­u­ates Re­gen­eron's an­ti­body com­bo

The Biden ad­min­is­tra­tion on Wednes­day an­nounced plans for a quick roll­out of the Pfiz­er/BioN­Tech Covid-19 vac­cine to kids ages 5 to 11 ear­ly next month, pend­ing FDA au­tho­riza­tion.

The ad­min­is­tra­tion plans to ini­ti­ate com­mu­ni­ty part­ner­ships with clin­ics, phar­ma­cies and hos­pi­tal sys­tems if that EUA hap­pens.

The an­nounce­ment comes as Pfiz­er’s vac­cine has shown 93% ef­fec­tive­ness in pre­vent­ing hos­pi­tal­iza­tions among ado­les­cents aged 12 to 18, ac­cord­ing to the CDC analy­sis of re­al-world da­ta re­leased on Tues­day.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER